Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pan

Showing results (971-980 of 1,203) with videos related to

Pageof 121
Sort By:
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|November 11, 2025
[Characterization of collateral circulation after anti-VEGF treatment for retinal vein occlusion]R Y Wang, P Chen, J H Zhang, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|November 11, 2025
[A case of unicentric chest wall Castleman disease-associated paraneoplastic autoimmune multiorgan syndrome]X Y Zhang, H Y Xie, C L Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 9, 2026
[External validation and incremental value assessment of the RR6 prognostic model in Chinese myelofibrosis patients treated with ruxolitinib: focusing on overall survival]N N Liu, B Li, T J Qin, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 20, 2022
[Epidemiological characteristics of COVID-19 caused by 2019-nCoV Delta variant in Shangyu district, Shaoxing of Zhejiang province]Y Y Wu, Z Wang, C L Chai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[The efficacy and safety of the patients of myelodysplastic syndromes-refractory anemia with excess blasts treated with decitabine alone or CAG/HAG regimen]Z F Xu, T J Qin, H L Zhang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 1, 2016
[Risk assessment on cervical cancer in women with cytology atypical squamous cells of undetermined significance but negative human papillomavirus]L Zhang, R M Feng, S Y Hu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 21, 2016
[A pilot study of ten-day decitabine regimen as initial therapy for newly diagnosed elderly patients with acute myeloid leukemia]T J Qin, Z F Xu, Y Zhang, et al.
The Journal of Infectious Diseases|July 4, 1998
Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from ChinaZ J Pan, D E Berg, R W van der Hulst, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 28, 2020
[Molecular features and prognostic value of RAS mutations in patients with myelodysplastic syndromes]H J Huang, B Li, T J Qin, et al.
Oncogene|October 7, 2014
USP37 directly deubiquitinates and stabilizes c-Myc in lung cancerJ Pan, Q Deng, C Jiang, et al.
Pageof 121

Showing results (971-980 of 1,203) with videos related to

Sort By:
Pageof 121
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|November 11, 2025
[Characterization of collateral circulation after anti-VEGF treatment for retinal vein occlusion]R Y Wang, P Chen, J H Zhang, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|November 11, 2025
[A case of unicentric chest wall Castleman disease-associated paraneoplastic autoimmune multiorgan syndrome]X Y Zhang, H Y Xie, C L Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 9, 2026
[External validation and incremental value assessment of the RR6 prognostic model in Chinese myelofibrosis patients treated with ruxolitinib: focusing on overall survival]N N Liu, B Li, T J Qin, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 20, 2022
[Epidemiological characteristics of COVID-19 caused by 2019-nCoV Delta variant in Shangyu district, Shaoxing of Zhejiang province]Y Y Wu, Z Wang, C L Chai, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[The efficacy and safety of the patients of myelodysplastic syndromes-refractory anemia with excess blasts treated with decitabine alone or CAG/HAG regimen]Z F Xu, T J Qin, H L Zhang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 1, 2016
[Risk assessment on cervical cancer in women with cytology atypical squamous cells of undetermined significance but negative human papillomavirus]L Zhang, R M Feng, S Y Hu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 21, 2016
[A pilot study of ten-day decitabine regimen as initial therapy for newly diagnosed elderly patients with acute myeloid leukemia]T J Qin, Z F Xu, Y Zhang, et al.
The Journal of Infectious Diseases|July 4, 1998
Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from ChinaZ J Pan, D E Berg, R W van der Hulst, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 28, 2020
[Molecular features and prognostic value of RAS mutations in patients with myelodysplastic syndromes]H J Huang, B Li, T J Qin, et al.
Oncogene|October 7, 2014
USP37 directly deubiquitinates and stabilizes c-Myc in lung cancerJ Pan, Q Deng, C Jiang, et al.
Pageof 121